Truist Securities Initiates Coverage of BioNTech SE - Nasdaq

Dec 23, 2024  · Fintel reports that on January 10, 2025, Truist Securities initiated coverage of BioNTech SE - Depositary Receipt () (NasdaqGS:BNTX) with a Buy recommendation. As of …


$172
OFF

BioNTech Initiated With A Buy At Truist - Markets Insider

2 weeks from now

6 days ago  · Truist initiated coverage of BioNTech (BNTX) with a Buy rating and $172 price target BioNTech is an oncology company “at heart, even though it was the COVID vaccine that made …

businessinsider.com

40%
OFF

Truist Rates BioNTech A Buy, Citing 40% Upside ... - Investing.com

2 weeks from now

6 days ago  · On Friday, Truist Securities began coverage on BioNTech shares (NASDAQ: BNTX) with a Buy rating, accompanied by a price target set at $172.00.The securities firm's analysis …

investing.com

40%
OFF

This Biotech Stock Is An 'oncology Powerhouse' With 40% Upside, …

2 weeks from now

5 days ago  · The firm's 12-month price target on the Nasdaq-traded shares of the German company is $172.

cnbc.com

40%
OFF

Truist Rates BioNTech A Buy, Citing 40% Upside Potential With Key …

2 weeks from now

6 days ago  · On Friday, Truist Securities began coverage on BioNTech shares (NASDAQ: BNTX) with a Buy rating, accompanied by a price target set at $172.00.The securities firm’s analysis …

investing.com

$172
OFF

Truist Securities Initiates Coverage On BioNTech With Buy Rating ...

2 weeks from now

6 days ago  · Truist Securities analyst Asthika Goonewardene initiates coverage on BioNTech (NASDAQ:BNTX) with a Buy rating and announces Price Target of $172.

sahmcapital.com

40%
OFF

Truist Rates BioNTech A Buy, Citing 40% Upside Potential With Key …

2 weeks from now

6 days ago  · On Friday, Truist Securities began coverage on BioNTech shares (NASDAQ: BNTX) with a Buy rating, accompanied by a price target set at $172.00.The securities firm's analysis …

investing.com

73%
OFF

BioNTech SE : Truist Securities Herhaalt Koopadvies

2 weeks from now

6 days ago  · Beurs gesloten - Nasdaq. Andere beurzen. 22:00:00 08-01-2025 Voorbeurs 13:19:13 122,15 USD-3,73%: 124,44 +1,87%: 13:02: BIONTECH SE : Truist Securities herhaalt …

marketscreener.com

FAQs about Truist Securities Initiates Coverage of BioNTech SE - Nasdaq Coupon?

Should you buy biontech se - depositary receipt (bntx)?

Fintel reports that on January 10, 2025, Truist Securities initiated coverage of BioNTech SE - Depositary Receipt () (NasdaqGS:BNTX) with a Buy recommendation. Analyst Price Forecast Suggests 14.22% Upside As of December 23, 2024, the average one-year price target for BioNTech SE - Depositary Receipt () is $139.52/share. ...

Should you buy biontech (bntx)?

Truist initiated coverage of BioNTech (BNTX) with a Buy rating and $172 price target BioNTech is an oncology company “at heart, even though it was the COVID vaccine that made it a household name,” the analyst tells investors in a research note. ...

Is biontech a good stock to buy?

HSBC boosted their price target on BioNTech from $97.00 to $136.00 and gave the stock a “buy” rating in a research note on Monday, October 7th. Finally, Canaccord Genuity Group increased their price objective on BioNTech from $171.00 to $171.44 and gave the company a “buy” rating in a research report on Wednesday, November 27th. ...

Will biontech buy bnt327/pm8002?

With the acquisition, BioNTech will obtain full global rights to the late-stage clinical asset BNT327/PM8002, an investigational bispecific antibody targeting PD-L1 and VEGF-A. Truist initiated with a Buy rating and a price target of $172. BioNTech’s oncology pipeline was previously seen as limited in value outside BNT316. ...

What is the price target for biontech se - depositary receipt ()?

As of December 23, 2024, the average one-year price target for BioNTech SE - Depositary Receipt () is $139.52/share. The forecasts range from a low of $100.23 to a high of $180.02. The average price target represents an increase of 14.22% from its latest reported closing price of $122.15 / share. ...

Who invests in biontech?

BioNTech's top institutional investors include GAMMA Investing LLC. How do I buy shares of BioNTech? Shares of BNTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension